Xiao He

机构：Peking University, Peking University Third Hospital

发表论文 20 篇 · 总被引 133 次 · h-index 7

代表论文

• EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment (2016 · Cancer Biology & Therapy · 被引 34)
• Quassinoids from Brucea javanica and attenuates lipopolysaccharide-induced acute lung injury by inhibiting PI3K/Akt/NF-κB pathways (2021 · Fitoterapia · 被引 25)
• Fullerenols as efficient ferroptosis inhibitor by targeting lipid peroxidation for preventing drug-induced acute kidney injury (2024 · Journal of Colloid and Interface Science · 被引 19)
• Based on Plasma Metabonomics and Network Pharmacology Exploring the Therapeutic Mechanism of Gynura procumbens on Type 2 Diabetes (2021 · Frontiers in Pharmacology · 被引 13)
• Therapeutic potential of targeting HSPA5 through dual regulation of two candidate prognostic biomarkers ANXA1 and PSAT1 in osteosarcoma (2020 · Aging · 被引 12)
• Multi-omics and machine learning framework reveals ABCG2 as a therapeutic target of Eleven Flavored Shenqi Tablets in clear cell renal cell carcinoma (2025 · Journal of Ethnopharmacology · 被引 10)